Page last updated: 2024-10-24

negative regulation of ATP metabolic process

Definition

Target type: biologicalprocess

Any process that stops, prevents or reduces the frequency, rate or extent of ATP metabolic process. [GO_REF:0000058, GOC:TermGenie, PMID:20695849]

Negative regulation of ATP metabolic process involves a complex interplay of regulatory mechanisms that modulate the production and utilization of ATP, the primary energy currency of cells. This process is essential for maintaining cellular homeostasis and ensuring proper functioning of various cellular processes. Here's a detailed description:

1. **Feedback Inhibition:** ATP itself can act as an allosteric inhibitor of key enzymes involved in its own production, such as phosphofructokinase (PFK-1) in glycolysis and citrate synthase in the citric acid cycle. This feedback mechanism prevents excessive ATP accumulation and ensures efficient energy production.

2. **Regulation of Enzyme Activity:** A variety of factors can influence the activity of enzymes involved in ATP metabolism. These factors include:
* **Phosphorylation:** Phosphorylation of specific enzymes can either activate or deactivate them. For instance, phosphorylation of PFK-1 stimulates its activity, promoting glycolysis and ATP production.
* **Allosteric Regulation:** Binding of specific molecules to regulatory sites on enzymes can alter their activity. For example, AMP, a product of ATP hydrolysis, can activate PFK-1, stimulating glycolysis.
* **Hormonal Control:** Hormones like insulin and glucagon play crucial roles in regulating ATP metabolism. Insulin promotes glucose uptake and utilization, leading to increased ATP production, while glucagon stimulates glycogen breakdown and gluconeogenesis, providing alternative substrates for ATP generation.

3. **Regulation of Substrate Availability:** The availability of substrates like glucose, fatty acids, and amino acids influences ATP production. Processes like glucose uptake, fatty acid mobilization, and amino acid catabolism are tightly regulated to ensure a constant supply of substrates for ATP generation.

4. **Control of Electron Transport Chain:** The electron transport chain in mitochondria is a critical component of ATP production. This chain's activity is regulated by factors such as oxygen availability, proton gradient across the mitochondrial membrane, and the presence of inhibitors like cyanide.

5. **Regulation of ATP Consumption:** Cellular processes that require ATP, such as muscle contraction, protein synthesis, and active transport, are carefully regulated to prevent excessive energy expenditure.

6. **Mitochondrial Biogenesis:** The number and activity of mitochondria, the powerhouses of the cell, are regulated in response to energy demands. When ATP levels are low, mitochondrial biogenesis increases to enhance ATP production capacity.

7. **Adaptive Mechanisms:** Cells can adapt to changes in energy availability by altering their metabolic pathways. For instance, under low oxygen conditions, cells switch to anaerobic respiration, producing ATP through glycolysis without the need for oxygen.

These regulatory mechanisms work in concert to maintain ATP levels within a narrow range, ensuring optimal cellular function and survival. Negative regulation of ATP metabolic process is crucial for maintaining cellular homeostasis and preventing energy depletion.
'"

Proteins (1)

ProteinDefinitionTaxonomy
Translocator protein[no definition available]Homo sapiens (human)

Compounds (34)

CompoundDefinitionClassesRoles
pk 11195PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylaminearomatic amide;
isoquinolines;
monocarboxylic acid amide;
monochlorobenzenes
antineoplastic agent
ro 5-48644'-chlorodiazepam: selectively binds peripheral benzodiazepine receptor
clonazepamclonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.

Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
1,4-benzodiazepinone;
monochlorobenzenes
anticonvulsant;
anxiolytic drug;
GABA modulator
nordazepamnordazepam : A 1,4-benzodiazepinone having phenyl and chloro substituents at positions 5 and 7 respectively; it has anticonvulsant, anxiolytic, muscle relaxant and sedative properties but is used primarily in the treatment of anxiety.

Nordazepam: An intermediate in the metabolism of DIAZEPAM to OXAZEPAM. It may have actions similar to those of diazepam.
1,4-benzodiazepinone;
organochlorine compound
anticonvulsant;
anxiolytic drug;
GABA modulator;
human metabolite;
sedative
diazepamdiazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.

Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
1,4-benzodiazepinone;
organochlorine compound
anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic
flunitrazepamflunitrazepam : A 1,4-benzodiazepinone that is nitrazepam substituted by a methyl group at position 1 and by a fluoro group at position 2'. It is a potent hypnotic, sedative, and amnestic drug used to treat chronic insomnia.

Flunitrazepam: A benzodiazepine with pharmacologic actions similar to those of DIAZEPAM that can cause ANTEROGRADE AMNESIA. Some reports indicate that it is used as a date rape drug and suggest that it may precipitate violent behavior. The United States Government has banned the importation of this drug.
1,4-benzodiazepinone;
C-nitro compound;
monofluorobenzenes
anxiolytic drug;
GABAA receptor agonist;
sedative
lorazepamLorazepam: A benzodiazepine used as an anti-anxiety agent with few side effects. It also has hypnotic, anticonvulsant, and considerable sedative properties and has been proposed as a preanesthetic agent.benzodiazepine
nitrazepamnitrazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome).

Nitrazepam: A benzodiazepine derivative used as an anticonvulsant and hypnotic.
1,4-benzodiazepinone;
C-nitro compound
anticonvulsant;
antispasmodic drug;
drug metabolite;
GABA modulator;
sedative
cm 7116norflutoprazepam: structurebenzodiazepine
oxazepamoxazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a hydroxy group at position 3 and phenyl group at position 5.

Oxazepam: A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.
1,4-benzodiazepinone;
organochlorine compound
anxiolytic drug;
environmental contaminant;
xenobiotic
temazepamTemazepam: A benzodiazepine that acts as a GAMMA-AMINOBUTYRIC ACID modulator and anti-anxiety agent.benzodiazepine
chlordesmethyldiazepambenzodiazepine
halazepamhalazepam: structureorganic molecular entity
alpidemimidazoles
n-desmethylflunitrazepam
7-aminonitrazepam7-aminonitrazepam: urinary metabolite of nitrazepambenzodiazepine
ro 20-18157-aminoflunitrazepam: flunitrazepam metabolite; structure given in first sourcebenzodiazepine
dx 9065
ro 11-6893Ro 11-6893: RN given refers to (R)-isomer
n,n-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamideN,N-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide: binds with high affinity to glial mitochondrial diazepam binding inhibitor receptors & increases mitochondrial steroidogenesisphenylindole
7-aminoclonazepambenzodiazepine
ro 5-3438Ro 5-3438: structure
n-desmethylflunitrazepamN-desmethylflunitrazepam: metabolite of flunitrazepam
ro 05-4082ID 690: methyl deriv of clonazepam; structure
ac-5216
cb 34CB 34: ligand for peripheral benzodiazepine receptors; structure in first source
n-(2-methoxybenzyl)-n-(4-phenoxypyridin-3-yl)acetamideN-(2-methoxybenzyl)-N-(4-phenoxypyridin-3-yl)acetamide: for imaging brain peripheral benzodiazepine receptors; structure in first source
ssr180575SSR180575: structure in first source
daa 1106
naluzotannaluzotan: an antidepressant and anti-anxiety agent; structure in first source
dpa-713
a 803467A 803467: an Nav1.8 sodium channel blocker; structure in first source
n-fluoroacetyl-n-(2,5-dimethoxybenzyl)-2-phenoxyanilineN-fluoroacetyl-N-(2,5-dimethoxybenzyl)-2-phenoxyaniline: a peripheral benzodiazepine receptor PET ligand; structure in first source
MS-417MS-417 : A member of the class of thienotriazolodiazepines that is the methyl ester of [(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]acetic acid. A bromodomain and extra-terminal domain (BET)-specific inhibitor that belongs to a group of thienodiazepine-based compoundsmethyl ester;
monochlorobenzenes;
thienotriazolodiazepine